Rebecca Cohen

1PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Feb 01, 2022
FDA Approval Summary: Pembrolizumab, Atezolizumab, and Cemiplimab-rwlc as Single Agents for First-Line Treatment of Advanced/Metastatic PD-L1-High NSCLC.

Oladimeji Akinboro, Erin Larkins, Lee H Pai-Scherf

Pageof 1

Frequent Collaborators

1 joint publications

Oladimeji Akinboro

1 joint publications

Yuan Xu

1 joint publications

Martha Donoghue